On March 18, 2021 IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) ("IntelGenx") reported that it will release its fourth quarter and full-year 2020 financial results after market close on Thursday, March 25, 2021 (Press release, IntelGenx, MAR 18, 2021, View Source [SID1234576912]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
An accompanying conference call will be hosted by Dr. Horst G. Zerbe, Chief Executive Officer, and Mr. Andre Godin, President and Chief Financial Officer, to discuss the results and provide a business update. Details of the conference call and webcast are below:
Fourth Quarter and Full-Year 2020 Results Conference Call Details:
Date: Thursday, March 25, 2021
Time: 4:30 p.m. ET
Live Call: 1- 877-876-9174 (Canada and the United States)
1- 785-424-1669 (International)
The call will also be broadcast live and archived on the Company’s website at www.intelgenx.com under "Webcasts" in the Investors section.